Please login to the form below

Not currently logged in
Email:
Password:

Grünenthal's Matt Lowe moves agency-side to join Creston Health

Takes up digital role at UK communications group

Creston_Health_Matt_LoweMatt Lowe has left Grünenthal, where he served as a senior marketing manager for its analgesic Palexia, to move agency-side.

He joins UK communications group Creston Health as head of digital and will oversee digital activities at Red Door Communications, Rock Medical Communications, Grapevine and Pan Advertising.

Reporting to the head of Creston Health Catherine Warne, Lowe will play a key role in developing digital health activities amongst the Creston Health companies.

“Having developed a number of successful digital projects, Matt is well versed in the restrictions and challenges that the industry has with online and offline digital tactics,” said Warne.

Lowe spent three years at Grünenthal and before that was at Sanofi, where he started as a GP/hospital sales representative and then moved into roles as a training manager and as a learning and development executive.

Over the past three years, Lowe has been focusing his marketing attention on traditional and innovative digital channels.

“With the restrictions on budgets, diminishing sales forces and the advent of digital as a serious marketing channel within the mix, my aim has been to educate myself and my teams on how to harness digital potential," he said.

5th March 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Lifting the fog to help Clinical Labs navigate IVDR 2022
In Vitro Diagnostic Regulation (IVDR 2022) was on the horizon: a new regulatory basis for laboratories to adhere to regarding their diagnostic equipment and tests. BD wanted to let their...
Empowering adolescents to manage emotional and mental health issues
1 in 10 UK children suffer with a mental health issue and alarmingly as many as 70% of these don’t receive the proper support they need. That’s why The Anna...
Reframing rare to increase earlier diagnosis of Gaucher Disease
Sanofi Genzyme wanted to reach haematologists; the specialist physicians most likely to encounter patients with Gaucher Disease prior to diagnosis. The problem? Gaucher Disease is considered very rare and its...